View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 200, Breast Cancer, Second Line
Protocol-ID: 1329 V1.0 (Mini), PEMB200, Breast Ca, second lineIndication(s)
- Breast Cancer (tripel negative); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 06.09.2019